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The plasma and urine metabolome of 192 overweight 12–15-year-old adolescents (BMI of 25.4 ± 2.3 kg/m2) were examined in order
to elucidate gender, pubertal development measured as Tanner stage, physical activity measured as number of steps taken daily,
and intra-/interindividual differences affecting the metabolome detected by proton NMR spectroscopy. Higher urinary excretion
of citrate, creatinine, hippurate, and phenylacetylglutamine and higher plasma level of phosphatidylcholine and unsaturated lipid
were found for girls compared with boys. The results suggest that gender differences in the metabolome are being commenced
already in childhood. The relationship between Tanner stage and the metabolome showed that pubertal development stage was
positively related to urinary creatinine excretion and negatively related to urinary citrate content. No relations between physical
activity and the metabolome could be identified. The present study for the first time provides comprehensive information about
associations between the metabolome and gender, pubertal development, and physical activity in overweight adolescents, which is
an important subject group to approach in the prevention of obesity and life-style related diseases. While this study is preliminary,
these results may have the potential to translate into clinical applicability upon further investigations; if biomarkers for Tanner stage
can be established, these might be used for identification of individuals susceptible to an early pubertal development.
1. Introduction
Metabolomics is a postgenomic technology that is given
great promise for human phenotyping and for assisting in
health assessment [1, 2]. Numerous metabolomics studies
have investigated the impact of anthropometric factors such
as age, gender, and obesity [3–5] in an attempt to understand
the human metabolome and interindividual differences.
However, these studies havemainly been conducted on either
newborns and infants [6, 7] or adults [3–5, 8], whereas studies
on children and adolescents are sparse [9–11]. Gu et al. [9]
studied the age-related metabolic changes in children of age
from newborn to 12 years and by NMR-based metabolomics
on urine samples. An age effect on the urinary metabolome
was identified as a distinct age-dependent clustering in PCA.
Metabolites found to be correlated with age included creati-
nine, creatine, glycine, betaine/TMAO, citrate, succinate, and
acetone. While creatinine increased with age, all the other
metabolites decreased [9].
The increase in obesity has been much more pronounced
in children and adolescents than other age groups [12], and
the prevalence of cardiovascular disease (CVD) among youth
is also increasing [13]. In fact, many life-style related diseases
are assumed to be commenced already in childhood and
during adolescence [14]. Thus, it was recently shown that
the level of plasma branched-chain amino acids, which are
getting increasing attention because of their potential role
in insulin sensitivity and secretion, was elevated already in
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obese children aged 8 to 13 years and correlated with insulin
resistance determined 18 months later [15]. Tanner stage was
first defined by Marshall and Tanner [16, 17] as a scale of
physical development based on external primary and sec-
ondary sex characteristics. Oldehinkel et al. [18] investigated
the relationship between specific mental health problems
and pubertal stage in adolescents in a Dutch prospective
cohort study and revealed that Tanner stage was positively
related to tiredness, irritability, rule-breaking behaviors, and
substance use and negatively to fears and somatic complaints.
Consequently, Tanner stage seems to be important for health
and well-being, and it could be advantageous to obtain
a better understanding of the metabolome of adolescents
and relation to pubertal development and life-style related
factors.
However, to our knowledge, no metabolomics stud-
ies on pubertal development have been reported. Pubertal
development involves complex physical and psychological
processes between childhood and adult life, ultimately result-
ing in the attainment of adult reproductive capacity [19].
The past decades age at sexual maturation has declined,
evident by a gradual younger age at menarche [20, 21]
and breast development [22] among girls, and earlier tes-
ticular development in boys [23]. The obesity epidemic is
thought to affect timing of pubertal development, and the
process of pubertal development is a critical period for
body composition development [24], but the association
between obesity and pubertal development is far from clear
[19]. Consequently, taken the increasing obesity epidemics
into consideration, this urges us to learn more about of
the process of pubertal development and metabolism, and
metabolomics may be a useful tool. Therefore, by using
nuclear magnetic resonance- (NMR-) based metabolomics,
the aim of the present study was to investigate the plasma and
urine metabolome of overweight adolescents and elucidate
intra- and interindividual differences, the influence of gender,
pubertal developmentmeasured asTanner stage, andphysical
activity.
2. Materials and Methods
2.1. Subjects. The samples used in present study included a
subset of samples from a larger intervention study presented
in Arnberg et al. [25, 26]. A total of 203 overweight ado-
lescents aged 12–15 years with the BMI (25.4 ± 2.3 kg/m2)
corresponding to a BMI > 25 kg/m2 for adults [27] were
recruited in the Copenhagen area using extractions from
the Civil Registration System. Firstly, a subgroup of 28
subjects was established and a urine sample and a blood
sample were collected from each of these at time point 0.
These samples served for studies on intra-/interindividual
differences. Twelve weeks later, urine and blood samples were
collected from all the 203 subjects, and sample sets from 192
subjects were included in the presentmetabolomics study. All
participants were free to consume their usual diet ad libitum
andmaintain daily physical activity. Samples were frozen and
stored at −80∘C until analysis.
2.2. NMRMeasurements. 1HNMR spectra were measured at
600.13MHz for proton on a Bruker Avance 600 spectrom-
eter equipped with a 5mm 1HTXI probe (Bruker BioSpin,
Rheinstetten, Germany) at 37∘C for blood plasma and 25∘C
for urine. A standard Bruker “ZGPR” pulse program that
applies a presaturation pulse sequence for water suppression
was used, and a total of 64 scans were collected into 32K data
points with a relaxation delay of 2 sec. A spectral width of
7288.63Hz and an acquisition time per scan of 2.25 sec were
applied in this study. Prior to analysis, samples were thawed
and homogenized using a vortex mixer. Urine samples were
centrifuged at 10,000 g for 5min to remove insolublematerial,
and 500 𝜇L supernatant was transferred to a 5mmNMR tube
and mixed with 100𝜇L of a 0.75M phosphate buffer solution
(containing 0.5% sodium trimethylsilyl propionate-d
4
(TSP))
prepared in D
2
O. Blood plasma samples were centrifuged at
10,000 g for 10min and 400𝜇L supernatant was transferred to
a 5mm NMR tube and then mixed with 200 𝜇L D
2
O.
2.3. Physical Activity. Physical activity was measured by
means of a short questionnaire daily, wherein participants
registered the number of counts measured by using pedome-
ters (Yamax, SW-200) for 7 consecutive days [25, 26].
2.4. Tanner Stage. Tanner stage was determined on a 5-point
scale according to an assessment of pubic hair development
in boys and breast stage in girls by using self-reported
questionnaires [25, 26].
2.5. Data Analysis. All 1H NMR spectra were automatically
phased and baseline-corrected using Topspin 3.0 software
(Bruker BioSpin, Rheinstetten, Germany). The 1H spectra
of blood plasma were referenced to the anomeric signal of
𝛼-glucose at 5.23 ppm, while the 1H spectra of urine were
referenced to the TSP signal at 0 ppm. Then, all spectra were
aligned by using the “icoshift” procedure [28] in MATLAB
(version R2012a, The Mathworks Inc., Natick, MA, USA).
The spectral region from 0.0 to 10.0 ppmwithout the residual
water resonance region from 4.7 to 5.0 ppm were normalized
to the total signal intensities of the NMR spectra, subdivided
into 0.01 ppm spectral regions, and integrated to 970 “bin”
data for multivariate data analysis.
PCAandOPLS-DA for classification andPLSR for regres-
sion were performed on mean-centered and Pareto-scaled
data by using the SIMCA 13.0 software (Umetrics, Umea˚,
Sweden), and a leave-one-out cross validation (LOOCV)
method was used to determine the optimal number of latent
variables for the models. 𝑅2𝑋 and 𝑅2𝑌 are the percentage of
the variance in 𝑋 and 𝑌 matrixes explained by the current
latent variable of themodel, respectively, while𝑄2𝑌 is the pre-
dictive capability of the model. In addition, the significance
test of themodel was performed by using CV-ANOVA [29] in
the SIMCA software. Outliers in the models were identified
as samples located far away from the 95%Hotelling’s T
2
confi-
dence limit. For urine, 7 outliers were identified and excluded
from the models resulting in a total of 185 samples from 115
girls and 70 boys. For blood, 3 outliers were identified and
excluded from the models resulting in a total of 189 samples
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from 119 girls and 70 boys. The NMR peaks were assigned
based on reported values [30, 31]. To aid spectral assignment,
two-dimensional (2D) 1H-1H correlation spectroscopy with
double-quantum filter (COSY), 2D 1H-1H total correlation
(TOCSY) and 2D 13C-1H heteronuclear single quantum
coherence (HSQC), experiments were performed on repre-
sentative samples of both urine and plasma. For analysis of
selected urinarymetabolites, integration of the specified ppm
area including citrate (CH
2
: 2.66–2.71 ppm), creatinine (CH
2
:
4.04–4.07 ppm), phenylacetylglutamine (CH: 7.33–7.39 ppm),
hippurate (CH
2
-2,6: 7.81–7.86 ppm), and urea ((NH
2
)
2
: 5.50–
6.10 ppm) in the NMR spectrum was performed by using
Topspin 3.0 software, followed by calculation of the relative
concentrations according to the known TSP concentration.
A linear mixed effects model was performed on the relative
concentration by using MIXED procedure in SAS 9.2 (SAS
Institute Inc, Cary, NC) to evaluate effect of Tanner stage and
gender on these metabolites. The mixed model included the
fixed effects of gender, Tanner stage, and their interaction,
while the intercept of model and individuals were used as a
random effect. The restricted maximum likelihood (REML)
approach [32] was used to estimate the variance compo-
nents of models. The degrees of freedom were determined
according to the method of Kenward and Roger [33], and
Akaike InformationCriterion [34] was performed to evaluate
the optimal model. In addition, least square (LS) means
procedures were used to calculate means and standard errors
and pairwise 𝑡-tests for multiple comparisons were estimated
by using the Tukey test. In this study, main and interaction
effects were considered statistically significant when 𝑃 <
0.05.
3. Results and Discussion
3.1. Inter-/Intrasubject Variations in the Urine and Blood
Metabolomes over a 12-Week Period. PCA scores plots
(Figure 1) show that, inmany cases, the two samples obtained
from the same subject are positioned close to each other;
however, intrasubject variations of urine and plasma samples
are still observed in both genders. A higher intersubject varia-
tion is observed for the urinemetabolome than for the plasma
metabolome (Figure 1), which is in agreement with previous
studies [35, 36]. The corresponding loadings from urine
(Figure 1(e)) and plasma (Figure 1(f)) sampleswere examined
in order to elucidate the spectral regions most susceptible
to inter-/intrasubject variations. The loadings revealed that
signals at 3.04 and 4.05 ppm from creatinine and a broad
signal from urea at 5.50–6.10 ppm contribute to intrasubject
variation in urine metabolome, while minor contribution
from hippurate signals at 3.96, 7.54, and 7.82 ppm is also evi-
dent (Figure 1(e)). Walsh et al. [36] have also concluded that
hippurate and creatinine were the metabolites contributing
most to variation in the urinary profiles. Figure 1(f) illustrates
that lipids and glucose in plasma mainly contribute to inter-
/intrasubject variation, which is in agreement with results
from Lenz et al. [35]. Krug et al. [8] reported that the human
metabolome is under continuous changes due to anabolic
(aftermeal) and catabolic (during fasting or physical exercise)
conditions of metabolism. Thus, the variations in the urine
and plasma metabolome can be ascribed to a range of factors
including dietary effects, physical exercise, and physiological
stress.
3.2. Gender Differences in the Urine and Blood Metabolomes.
Gender was found to have a pronounced impact on the
urine and plasma metabolomes, and O-PLS models that
could discriminate the two gender could be built from the
metabolomics data obtained both for urine (𝑅2𝑋 = 32.8%;
𝑅
2
𝑌 = 50.4%; 𝑄2 = 28.3%; 𝑃 < 0.0001) (Figure 2(c)), which
included samples from 115 girls and 70 boys, and plasma
(𝑅2𝑋 = 73.8%; 𝑅2𝑌 = 46.4%; 𝑄2 = 26.5%; 𝑃 < 0.0001)
(Figure 2(d)), which included samples from 119 girls and 70
boys.
Inspection of the corresponding S-line plot from the
urine data (Figure 2(e)) revealed that gender differences
could be ascribed to differences in the urinary content of
citrate (2.53, 2.56, 2.67, and 2.70 ppm), creatinine (3.04 and
4.05 ppm), and urea (5.50–6.10 ppm). Mixed model analysis
shows that the concentrations of citrate and creatinine were
significantly higher in girls, while urea content was lower
in girls compared with boys (Table 1). The results are in
agreement with previous studies on adults [3, 4, 37] where
higher urinary levels of citrate have been observed in females
compared with males. It has been reported that the excretion
of urinary citrate is regulated by sex hormones such as
estrogen [38] and testosterone [39], which may contribute
to the gender differences in urinary citrate. However, the
results concerning creatinine are opposing previous studies
on adults who all reported that urinary creatinine levels were
higher in males than females. A positive association between
urinary excretion of creatinine and muscle mass has been
reported by Kochhar et al. [3] and Oterdoom et al. [40]. Neu
et al. [41] investigated the influence of puberty on muscle
development and found that the gender difference in forearm
muscle growth decreased until pubertal stage 3 and then
increased again. Generally, girls begin and complete each
puberty stage earlier than boys, which was also reflected in
our study (Table 1). Thus, the contrasting results about uri-
nary creatininemay be related to a highermusclemass in girls
relative to boys. Since urea is the major product of protein
catabolism, the higher urinary urea excretion in boys may be
caused by a higher protein intake or a higher protein turnover.
A higher leucine oxidation in males than in females has been
reported, which could cause the gender-specific difference in
protein utilization [42, 43]. In addition, females may utilize
less protein as an energy source owing to a greater part of
exercise energy from fat [44]. In addition, Table 1 shows that
girls have a relatively higher urinary excretion of hippurate
and phenylacetylglutamine than boys, which is different from
results obtained for adults aged 40–59 years [45]. They found
a higher hippurate excretion in men compared to women,
but no gender difference in phenylacetylglutamine excretion.
Consequently, it appears that many of the gender effects
observed on the urine metabolome are being commenced
already in childhood, while some differences are still evident
between adolescents and adults.
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Figure 1: Intrasubject variation in the urine and plasma metabolome of adolescents over a 12-week interval: (a) PCA score plot of urine
samples from boys (PC1 explains 28.3% and PC2 explains 16.4% of the variation); (b) PCA score plot of plasma samples from boys (PC1
explains 64.3% and PC2 explains 14.4% of the variation); (c) PCA score plot of urine samples from girls (PC1 explains 24.3% of the variation
and PC2 explains 10.2% of the variation); (d) PCA score plot of plasma samples from girls (PC1 explains 55.7% and PC2 explains 11.6% of the
variation); (e) PC1 loadings of urine samples; (f) PC1 loadings of plasma samples. The same subject is indicated by the same color in PCA
score plots and the arrow points fromweek 0 to week 12. Assignments: 1: creatinine (3.04 and 4.05 ppm); 2: urea (5.50–6.10 ppm); 3: hippurate
(3.96, 7.54, and 7.82 ppm); 4: lipids; 5: glucose.
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Figure 2: Gender difference (e: boys; 󳵳: girls) in the urine and plasma metabolome of adolescents: (a) PCA score plot of urine samples (PC1
explains 20.3% and PC3 explains 5.4% of the variation); (b) PCA score plot of plasma samples (PC1 explains 59.2% and PC6 explains 2.3% of
the variation); (c) OPLS-DA score plot of urine samples (1 predictive and 2 orthogonal components;𝑅2𝑋 = 32.8%;𝑅2𝑌 = 50.4%;𝑄2 = 28.3%;
𝑃 < 0.0001); (d) OPLS-DA score plot of plasma samples (1 predictive and 3 orthogonal components;𝑅2𝑋 = 73.8%;𝑅2𝑌 = 46.4%;𝑄2 = 26.5%;
𝑃 < 0.0001); (e) S-line plot of urine samples; (f) S-line plot of plasma samples. Assignments: 1: citrate (2.53, 2.56, 2.67, and 2.70 ppm);
2: creatinine (3.04 and 4.05 ppm); 3: urea (5.50–6.10 ppm); 4: lipoproteins (0.84 and 1.26 ppm); 5: choline (3.20 ppm); 6: phosphocholine
(3.22 ppm); 7: unsaturated lipids (5.29 ppm).
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Table 1: Mixed models of Tanner stage and gender effects in overweight adolescents on urinary metabolitesa.
𝑁
b Citrate Creatinine Hippurate Phenylacetylglutamine Urea
Gender D 70 27.1 ± 2.4
b 262.9 ± 5.1b 46.6 ± 3.5b 38.9 ± 2.4 1358.2 ± 48.4a
C 115 36.4 ± 2.7a 280.0 ± 5.4a 57.1 ± 3.9a 45.4 ± 2.6 1087.3 ± 53.5b
Tanner stage
1 D: 5; C: 2 49.2 ± 6.8a 262.8 ± 12.6b 39.6 ± 9.0 33.7 ± 6.1 1326.5 ± 124.0
2 D: 30; C: 7 29.7 ± 2.5bc 262.3 ± 6.9b 57.0 ± 5.0 41.2 ± 3.3 1211.8 ± 67.9
3 D: 18; C: 53 30.8 ± 1.7b 257.7 ± 4.3b 57.4 ± 3.0 47.5 ± 2.2 1256.6 ± 43.1
4 D: 13; C: 43 25.1 ± 1.9c 270.4 ± 6.6b 56.6 ± 3.8 48.3 ± 2.6 1257.8 ± 54.7
5 D: 4; C: 10 24.1 ± 4.6bc 303.8 ± 8.9a 48.5 ± 6.4 40.0 ± 4.3 1060.9 ± 87.7
Significant effects (P values)
Gc 0.01 0.02 0.05 0.07 0.0002
Td 0.005 0.0003 0.30 0.06 0.29
G ∗ T 0.24 0.81 0.73 0.009 0.03
aValues are the relative concentrations according to a known TSP concentration and expressed mean ± SE; bNumber of subjects (D: boys; C: girls); cGender;
dTanner stages; Different letters indicate significant differences within columns (P < 0.05).
Inspection of the S-line plot for blood data shows that the
discrimination of the two genders mainly can be ascribed to
differences in lipoproteins (0.84 and 1.26 ppm), phosphatidyl-
choline (3.22 ppm), and unsaturated lipid (5.29 ppm) and
lower levels of choline (3.20 ppm) in girls compared with
boys (Figure 2(f)). Gender differences in blood lipids have
also previously been reported for 17-year-old Scandinavians
[5]. According to Brindle et al. [46], the region at 3.22 ppm
can be assigned to –N(CH
3
)3+ groups in molecules, which
contain the choline moiety, mostly phosphatidylcholine from
HDL. The –N(CH
3
)3+ groups could also be coupled with a
higher level of unsaturated lipids in the blood from girls,
implying that the phospholipids aremore unsaturated in girls
compared to boys [5]. In addition, phosphatidylcholine is a
major structural constituent of cell membranes. Thus, our
results could possibly reflect that girls have a higher overall
plasma membrane turnover compared with boys [5]. A study
onmice also found gender differences in phosphatidylcholine
[47]. A survey in 2007-2008 estimated mean daily intake of
choline in US population and reported that males have a
higher choline requirement than females for all age groups
above 12 years old [48], which could possibly explain the
higher content of choline in the plasma from boys.
3.3. Effect of Pubertal Development Stage on the Urine and
Blood Metabolomes. PCA of the NMR urine profiles of 115
girls and 70 boys indicated a tendency for a clustering
according to Tanner stage (Figures 3(a) and 3(b)), revealing
that Tanner stage is reflected in the urine metabolome. PLS
models with Tanner stage as response variable were therefore
constructed in order to elucidate the relation between urine
metabolite profile and Tanner stage for boys (𝑅2𝑋 = 27.1%;
𝑅
2
𝑌 = 51.9%; 𝑄2 = 25.5%; 𝑃 < 0.001) and girls (𝑅2𝑋 =
37.3%; 𝑅2𝑌 = 69.4%; 𝑄2 = 24.6%; 𝑃 < 0.0001), respectively
(Figures 3(c) and 3(d)). The corresponding PLS1 loadings
indicate that urinary creatinine excretion is positively corre-
lated with Tanner stage in both boys (Figure 3(e)) and girls
(Figure 3(f)), which is supported by results from quantifica-
tion of creatinine (Table 1). Oterdoom et al. [40] and Wang
et al. [49] found a positive association between muscle mass
and urinary excretion of creatinine, and increases in muscle
mass increases during pubertal development is probably
encompassed in the present findings. In addition, a study on
creatinine levels surveyed a large US population with ages
ranging from 6 to 70 years reported a gradual increase in
urinary creatinine concentration up to an age between 20 and
29 years [50].
Intriguingly, a negative correlation is observed between
urinary citrate excretion and Tanner stage, which is more
evident in boys than in girls (Figures 3(e) and 3(f); Table 1).
It has been reported that the flux of citrate through the TCA
cycle is regulated by gender hormones such as testosterone
[39]. Costello et al. [51] also found that citrate oxidation
in rat ventral prostate was stimulated by testosterone. In
addition, a strong correlation between estrogen actions and
citrate excretion was reported by Dey et al. [38], who found
that estrogen replacement increased urinary citrate excretion
in postmenopausal women. Therefore, the decrease in the
excretion of citrate is most likely attributed to changes in sex
hormones during pubertal development.
Loading plots indicate that the aromatic region of 1H
NMR spectra (6.80–8.10 ppm) involving mainly hippurate
and phenylacetylglutamine to some extent was correlated
with Tanner stage, especially for girls (Figure 3(f)). Quantifi-
cation of hippurate and phenylacetylglutamine by integration
of the NMR signals revealed no significant effect of Tanner
stage on urinary hippurate, while phenylacetylglutamine
tended to be significantly affected by Tanner stage (𝑃 = 0.06)
(Table 1). Gu et al. [9] reported that urinary hippurate excre-
tionmay vary less during childhood development, although a
relatively large variation in hippurate with age was found for
adults by Psihogios et al. [37]. In addition, the data reported
by Swann et al. [52] indicated that urinary phenylacetylglu-
tamine concentrations were increased with age in adults. Uri-
nary hippurate and phenylacetylglutamine have often been
related to the activity of the gut microflora [53], so our results
suggest that the gut microflora may vary with Tanner stage.
Thus, further studies including a more detailed description
of the gut microflora as function of pubertal development
could be of great interest confirming this hypothesis. For
blood, a relatively low correlation was obtained between the
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Figure 3: (a) PCA score plot of boys (PC1 explains 21.4% and PC3 explains 6.3% of the variation); (b) PCA score plot of girls (PC1 explains
19.7% and PC4 explains 5.9% of the variation) obtained for the urine metabolome of adolescents and showing Tanner stage (󳵳: stage 1; Q:
stage 2; e: stage 3; 󳀅: stage 4; 󳶃: stage 5). (c) PLSR prediction plot of Tanner stage in boys (the optimal number of PLSs = 2; 𝑅2𝑋 = 27.1%;
𝑅
2
𝑌 = 51.9%; 𝑄2 = 25.5%; 𝑃 < 0.001); (d) PLSR prediction plot of Tanner stage in girls (the optimal number of PLSs = 4; 𝑅2𝑋 = 37.3%;
𝑅
2
𝑌 = 69.4%; 𝑄2 = 24.6%; 𝑃 < 0.0001); (e) PLS1 loadings of boys; (f) PLS1 loadings of girls. Assignments: 1: citrate (2.53, 2.56, 2.67, and
2.70 ppm); 2: creatinine (3.04 and 4.05 ppm); 3: hippurate (3.96, 7.54 and 7.82 ppm); 4: phenylacetylglutamine (7.35 ppm).
metabolite profile and Tanner stage (𝑅2𝑌 = 40.6% and 𝑄2 =
23.9% for boys; 𝑅2𝑌 = 33.6% and 𝑄2 = 16.0% for girls)
(Figure S1, See the Supplementary Material available online
at http://dx.doi.org/10.1155/2014/537157).
3.4. Effect of Physical Activity on the Urine and Blood Met-
abolomes. Several studies have reported the use of NMR-
based metabolomics to study impact of physical exercise
on the biofluid metabolome [54–59]. In the present study
8 BioMed Research International
the relation between the metabolome and physical activity
measured as number of steps taken daily was elucidated. No
strong correlation could be identified neither between the
blood plasma nor the urine metabolome and daily physical
activity (Figure S2, Supplementary Material). Thus, it was
not possible to demonstrate a relation between moderate
physical activity and the metabolome. Possibly more extreme
variations in physical activity would have a more clear effect
on the metabolome; however, this remains to be established
in future studies.
4. Conclusions
In summary, our findings showed that creatinine, hippurate,
and urea in urine and glucose and lipids in plasma are the
main metabolites giving rise to inter-/intrasubject variations.
We showed that girls have a higher urinary excretion of
citrate, creatinine, hippurate, and phenylacetylglutamine and
higher plasma level of phosphatidylcholine and unsaturated
lipid as compared with boys. In addition, we have identified
potential metabolites including creatinine and citrate, which
exhibit a relation to pubertal development stage as measured
by the Tanner stage. To our knowledge, the present study is
the first to elucidate the relation between themetabolome and
pubertal development stage.
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